<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title></journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2012.1091</article-id>
<article-id pub-id-type="publisher-id">mmr-06-06-1399</article-id>
<article-categories>
<subj-group>
<subject>Articles</subject></subj-group></article-categories>
<title-group>
<article-title>The metabolic syndrome of fructose-fed rats: Effects of long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids. V. Post-mortem findings</article-title></title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>MELLOUK</surname><given-names>ZOHEIR</given-names></name><xref rid="af1-mmr-06-06-1399" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>LOUCHAMI</surname><given-names>KARIM</given-names></name><xref rid="af2-mmr-06-06-1399" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>HUPKENS</surname><given-names>EMELINE</given-names></name><xref rid="af2-mmr-06-06-1399" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>SENER</surname><given-names>ABDULLAH</given-names></name><xref rid="af2-mmr-06-06-1399" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author">
<name><surname>YAHIA</surname><given-names>DALILA AIT</given-names></name><xref rid="af1-mmr-06-06-1399" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author">
<name><surname>MALAISSE</surname><given-names>WILLY J.</given-names></name><xref rid="af2-mmr-06-06-1399" ref-type="aff">2</xref><xref ref-type="corresp" rid="c1-mmr-06-06-1399"/></contrib></contrib-group>
<aff id="af1-mmr-06-06-1399">
<label>1</label>Department of Biology, Es-S&#x000E9;nia University, Es-S&#x000E9;nia 31000, Oran, Algeria</aff>
<aff id="af2-mmr-06-06-1399">
<label>2</label>Laboratory of Experimental Hormonology, Universit&#x000E9; Libre de Bruxelles, B-1070 Brussels, Belgium</aff>
<author-notes>
<corresp id="c1-mmr-06-06-1399">Correspondence to: Professor Willy J. Malaisse, Laboratory of Experimental Hormonology, Universit&#x000E9; Libre de Bruxelles, 808 Route de Lennik, Brussels B-1070, Belgium, E-mail: <email>malaisse@ulb.ac.be</email></corresp></author-notes>
<pub-date pub-type="ppub">
<month>12</month>
<year>2012</year></pub-date>
<pub-date pub-type="epub">
<day>20</day>
<month>09</month>
<year>2012</year></pub-date>
<volume>6</volume>
<issue>6</issue>
<fpage>1399</fpage>
<lpage>1403</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>06</month>
<year>2012</year></date>
<date date-type="accepted">
<day>17</day>
<month>09</month>
<year>2012</year></date></history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2012, Spandidos Publications</copyright-statement>
<copyright-year>2012</copyright-year>
<license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0">
<license-p>This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.</license-p></license></permissions>
<abstract>
<p>The present study deals with the possible effects of dietary &#x003C9;3 and &#x003C9;6 fatty acids upon the metabolic syndrome found in rats exposed for 8 weeks to a diet containing 64&#x00025; (w/w) D-fructose instead of starch. Fructose-fed rats were found to display a modest increase in plasma albumin and protein concentration and more pronounced increases in plasma urea, creatinine, phospholipids, triglycerides and cholesterol concentrations, glycated hemoglobin concentration and liver contents of cholesterol, triglycerides and phospholipids. The plasma concentrations of HDL-cholesterol, calcium and iron were decreased, however, in the fructose-fed rats. In general, the partial substitution of sunflower oil by either safflower oil or salmon oil opposed the metabolic perturbations otherwise associated with the fructose-induced metabolic syndrome in the fructose-fed rats, with salmon oil demonstrating particular efficacy. Consideration is given to the possible biological determinants of these perturbations and their attenuation in rats exposed to safflower or salmon oil.</p></abstract>
<kwd-group>
<kwd>metabolic syndrome</kwd>
<kwd>fructose-fed rats</kwd>
<kwd>long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids</kwd></kwd-group></article-meta></front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>The first four articles in this series concerned intraperitoneal glucose tolerance tests (<xref rid="b1-mmr-06-06-1399" ref-type="bibr">1</xref>), the time course of changes in food intake, body weight, plasma glucose and insulin concentrations and insulin resistance (<xref rid="b2-mmr-06-06-1399" ref-type="bibr">2</xref>), the secretory behaviour of isolated pancreatic islets (<xref rid="b3-mmr-06-06-1399" ref-type="bibr">3</xref>) and the metabolism of D-glucose in isolated pancreatic islets (<xref rid="b4-mmr-06-06-1399" ref-type="bibr">4</xref>) in fructose-fed rats. Comparisons were made between the results for control female rats exposed from the 8th week after birth and for the ensuing 8 weeks to a diet containing 64&#x00025; (w/w) starch and 5&#x00025; (w/w) sunflower oil (Ssun rats) and female rats exposed over the same period to a diet containing 64&#x00025; D-fructose and 5&#x00025; sunflower oil (Fsun rats) or 3.4&#x00025; sunflower oil mixed with 1.6&#x00025; salmon oil (Fsal rats) or safflower oil (Fsaf rats). The selection of these experimental conditions was based on an extensive examination of the relevant literature, as documented in a review study dealing mainly with the influence of nutritional factors on the fructose-induced metabolic syndrome (<xref rid="b5-mmr-06-06-1399" ref-type="bibr">5</xref>). The present report extends these observations to a first set of post-mortem investigations dealing <italic>inter alia</italic> with: the percentage of glycated hemoglobin in blood and liver glucokinase activity relating to carbohydrate metabolism; plasma concentration and liver content of cholesterol, triglycerides and phospholipids in respect to lipid metabolism; and protein, albumin, urea and creatinine concentrations in plasma in respect to nitrogen-rich compounds.</p></sec>
<sec sec-type="methods">
<title>Materials and methods</title>
<p>The four groups of female Wistar rats used in the present study were the same as those defined in the first report in this series. At sacrifice, blood was sampled by cardiac puncture following overnight fasting.</p>
<p>The methods used for the measurement of the plasma concentration of albumin (<xref rid="b2-mmr-06-06-1399" ref-type="bibr">2</xref>), blood concentration of glycated hemoglobin (<xref rid="b2-mmr-06-06-1399" ref-type="bibr">2</xref>), liver protein content (<xref rid="b6-mmr-06-06-1399" ref-type="bibr">6</xref>) and hepatic glucokinase activity (<xref rid="b7-mmr-06-06-1399" ref-type="bibr">7</xref>) have been described previously. The kits used for the measurement of the plasma concentration of urea and creatinine (Biocon, V&#x000F6;hl-Marienhagen, Germany), calcium (Spinreact S.A., Girona, Spain), iron (Randox Laboratories Ltd., Crumlin, UK), plasma and liver triglycerides and phospholipids (Spinreact S.A.) plasma and liver cholesterol (Biolabo, Maizy, France), plasma HDL-cholesterol (Biocon) were obtained from the sources cited in parentheses.</p>
<p>The plasma albumin concentration (<xref rid="b2-mmr-06-06-1399" ref-type="bibr">2</xref>) and percentage of glycated hemoglobin (<xref rid="b2-mmr-06-06-1399" ref-type="bibr">2</xref>) are listed in the present report for purpose of comparison. All results are presented as the mean value &#x000B1; SEM (standard error of the mean) together with the number of individual determinations (n). The statistical significance of a difference between mean values was assessed using the Student&#x02019;s t-test.</p></sec>
<sec sec-type="results">
<title>Results</title>
<sec>
<title>Plasma data</title>
<p>The mean plasma concentrations of albumin, urea, creatinine, phospholipids, triglycerides and total cholesterol were all higher (P&lt;0.07 or less) in the Fsun rats than in the Ssun rats (<xref rid="tI-mmr-06-06-1399" ref-type="table">Table I</xref>), such a difference being, in relative terms, most pronounced in the case of urea, creatinine, phospholipids, triglycerides and total cholesterol. The plasma concentrations of calcium, iron and HDL-cholesterol, however, were lower in the Fsun rats than in the Ssun rats (P&lt;0.06 or less).</p>
<p>The six variables listed in <xref rid="tI-mmr-06-06-1399" ref-type="table">Table I</xref> which yielded higher mean values in the Fsun rats than in the Ssun rats displayed a comparable pattern when the results recorded in the fructose-fed rats were compared with those of the starch-fed animals. Thus, in the Fsun, Fsal and Fsaf rats, the measurements averaged, respectively, 148.0&#x000B1;6.3 (n&#x0003D;36; P&lt;0.001), 114.9&#x000B1;3.3 (n&#x0003D;30; P&lt;0.001) and 130.6&#x000B1;4.0&#x00025; (n&#x0003D;36; P&lt;0.001) of those in the Ssun rats (100.0&#x000B1;1.9&#x00025;; n&#x0003D;36). In this respect, the mean results recorded in the Fsal and Fsaf rats were significantly lower (P&lt;0.025 or less) than those in the Fsun rats. The values in the Fsal rats were also significantly lower (P&lt;0.005) than those in the Fsaf rats.</p>
<p>Relative to the differences between the Fsun and Ssun rats for these six variables (100.0&#x000B1;6.7&#x00025;; n&#x0003D;36), those found between the Fsal or Fsaf rats and Ssun rats averaged 33.6&#x000B1;7.0 (n&#x0003D;30; P&lt;0.001) and 71.8&#x000B1;7.0&#x00025; (n&#x0003D;36; P&lt;0.005), respectively. That is, the increments recorded in the Fsaf rats averaged, for the same six variables, 272.7&#x000B1;34.2&#x00025; (n&#x0003D;36; P&lt;0.001) of the mean corresponding increments in the Fsal rats (100.0&#x000B1;30.9&#x00025;; n&#x0003D;30).</p>
<p>A comparable situation prevailed for the three variables, plasma HDL-cholesterol, calcium and iron concentrations, which had a lower value in the Fsun rats than in the Ssun rats. Indeed, relative to the mean value recorded in the latter rats (100.0&#x000B1;3.6&#x00025;; n&#x0003D;18), those determined in the Fsun, Fsal and Fsaf rats averaged 74.8&#x000B1;3.1 (n&#x0003D;18; P&lt;0.001), 113.0&#x000B1;5.4 (n&#x0003D;15; P&lt;0.05) and 90.9&#x000B1;4.2&#x00025; (n&#x0003D;18; P&gt;0.11), respectively. The mean results recorded in the Fsal and Fsaf rats were thus significantly higher (P&lt;0.005 or less) than those in the Fsun rats. Moreover, the values collected in the Fsal rats were also significantly higher (P&lt;0.004) than those in the Fsaf rats. In the latter rats, they were not significantly different (P&gt;0.11) from those in the Ssun rats, whilst those in the Fsal rats were higher (P&lt;0.05 or less) than those in the Ssun rats.</p></sec>
<sec>
<title>Blood data</title>
<p>The concentration of hemoglobin in the blood did not differ significantly among the four groups of rats, with an overall mean value of 503&#x000B1;36 mg/ml (n&#x0003D;23). The percentage of glycated hemoglobin, however, was significantly higher (P&lt;0.001) in the fructose-fed than in the starch-fed rats (<xref rid="tII-mmr-06-06-1399" ref-type="table">Table II</xref>). In the former rats, it again displayed a Fsun &gt;Fsaf &gt;Fsal hierarchy (P&lt;0.001).</p></sec>
<sec>
<title>Liver data</title>
<p>The protein content of liver homogenates, expressed relative to wet weight, did not differ significantly among the four groups of rats (<xref rid="tIII-mmr-06-06-1399" ref-type="table">Table III</xref>), with an overall mean value of 204&#x000B1;7 &#x003BC;g/mg wet wt. (n&#x0003D;23). The data concerning the protein content of the liver were confirmed in an independent assay in which no significant difference (P&gt;0.20 or more) was found among the mean values recorded in the four groups of rats. In the latter assay, the protein content of the heart or kidney also failed to differ among the four groups of rats, the data recorded in Fsun, Fsal and Fsal rats averaging, respectively, 107.3&#x000B1;5.8 (n&#x0003D;12), 106.7&#x000B1;5.4 (n&#x0003D;10) and 100.9&#x000B1;9.1&#x00025; (n&#x0003D;10) of the corresponding mean values in the Ssun rats (100.0&#x000B1;8.6&#x00025;; n&#x0003D;10). Within the same assay, no significant differences were detected among the four groups of rats in terms of the protein content of the parametrial or visceral adipose tissue. The absolute values determined in adipose tissue were, however, one order of magnitude lower than in the liver, representing in the parametrial and visceral adipose tissue no more than 9.4&#x000B1;1.1 and 11.9&#x000B1;1.2&#x00025; of the mean value in liver samples (100.0&#x000B1;6.5&#x00025;; n&#x0003D;23 in all three cases).</p>
<p>As judged from triplicate measurements of liver glucokinase activity conducted in each of two separate assays, with a correlation coefficient between the latter two assays of &#x0002B;0.922 (n&#x0003D;22; P&lt;0.001), the results recorded in the Fsun rats did not differ significantly (P&gt;0.2 or more) from those found in the Ssun or Fsaf rats (<xref rid="tIII-mmr-06-06-1399" ref-type="table">Table III</xref>). However, the values found in the Fsaf rats appeared higher (P&lt;0.06) than those recorded in the Ssun rats. Finally, in the Fsal rats, the activity of glucokinase exceeded that found in the Ssun (P&lt;0.02), Fsun (P&lt;0.02) and Fsaf rats (P&lt;0.05).</p>
<p>The mean values for the liver content of cholesterol, triglycerides and phospholipids in the four groups of rats are listed in <xref rid="tIII-mmr-06-06-1399" ref-type="table">Table III</xref>. These three variables displayed a comparable hierarchy in the four groups of rats, the overall mean values in the Fsun, Fsaf and Fsal rats averaging, respectively, 156.2&#x000B1;3.8 (n&#x0003D;18), 139.5&#x000B1;3.6 (n&#x0003D;18) and 118.2&#x000B1;1.8&#x00025; (n&#x0003D;15) of the mean corresponding values in the Ssun rats (100.0&#x000B1;1.1&#x00025;; n&#x0003D;18). The latter four mean values differed significantly (P&lt;0.004 or less) from one another.</p></sec></sec>
<sec sec-type="discussion">
<title>Discussion</title>
<p>The results recorded in the present study are shown in <xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1</xref>. It documents that, for the majority of variables, specifically the percentage of glycated hemoglobin (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1A</xref>), liver cholesterol, triglyceride and phospholipid content (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1B</xref>) and plasma concentration of albumin, urea, creatinine, phospholipids, triglycerides and total cholesterol (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1C</xref>), the measurements recorded in the Fsun rats were invariably higher than those determined in the Ssun rats. In the fructose-fed rats, the substitution of part of the sunflower oil by an equal amount of either safflower oil or salmon oil minimized the relative magnitude of such increases, with salmon oil having the greatest minimizing effect. Conversely, the substitution of starch by D-fructose in the diet containing sunflower oil decreased the plasma concentration of calcium, iron and HDL-cholesterol (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1D</xref>). The effect of D-fructose was again opposed by the substitution of some of the sunflower oil by either safflower oil or salmon oil, the latter having the stronger effect. Two variables, that is, the blood hemoglobin concentration and liver protein content, were not significantly affected by the dietary manipulations (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1E</xref>). Finally, the activity of liver glucokinase was markedly higher in the Fsal rats than in the other three groups of rats (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1F</xref>). Thus, in several respects, the partial substitution of sunflower oil by either safflower oil or salmon oil corrected, at least to some extent, the biochemical perturbations found in the metabolic syndrome of the fructose-fed rats (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1A-C</xref>) and, on occasion, even increased the parameter under consideration above the level found in the control Ssun rats (<xref rid="f1-mmr-06-06-1399" ref-type="fig">Fig. 1D and F</xref>).</p>
<p>The determinants responsible for these diet-induced changes in metabolic variables remain, to some extent, a matter of speculation, as recently reviewed elsewhere (<xref rid="b5-mmr-06-06-1399" ref-type="bibr">5</xref>). The following considerations should not be ignored, however. In terms of carbohydrate metabolism and as judged from the percentage of glycated hemoglobin, the present findings are consistent with the well-known perturbation of glucose homeostasis in fructose-fed rats, currently attributed to an increase in hepatic glucose output and peripheral insulin resistance (<xref rid="b5-mmr-06-06-1399" ref-type="bibr">5</xref>). This supports the view that the dietary supply of &#x003C9;3 fatty acids to the Fsal rats and, to a lesser extent, that of &#x003C9;6 fatty acids, in this case mainly C18:2&#x003C9;6 to the Fsal rats (<xref rid="b1-mmr-06-06-1399" ref-type="bibr">1</xref>) may oppose such an unfavorable effect of the fructose-rich diet (<xref rid="b5-mmr-06-06-1399" ref-type="bibr">5</xref>). Incidentally, in the Fsal rats, the glycogen content of the liver did not differ (98.5&#x000B1;7.5&#x00025;; n&#x0003D;6) from that in the Ssun rats (100.0&#x000B1;8.3&#x00025;; n&#x0003D;6), whilst being decreased (P&lt;0.007) to 71.8&#x000B1;4.9&#x00025; (n&#x0003D;11) of the same reference value in the other fructose-fed rats (data not shown). The major novel information provided by the present study in respect to carbohydrate metabolism relates to the measurements of liver glucokinase activity. The results of such measurements, as given in <xref rid="tIII-mmr-06-06-1399" ref-type="table">Table III</xref>, document a higher activity of glucokinase in the liver of the Fsal rats than in the other 3 groups of rats (P&lt;0.05 or less). The higher liver glucokinase activity in the Fsal rats, as compared with either the Fsun or Fsaf rats, is reminiscent of the higher glucokinase activity found in the pancreatic islet homogenates of control rats, as compared with second generation rats depleted in long-chain polyunsaturated &#x003C9;3 fatty acids, a difference tentatively ascribed to inhibition of the enzyme by endogenous long-chain fatty acyl-coenzyme A in the &#x003C9;3-depleted rats (<xref rid="b7-mmr-06-06-1399" ref-type="bibr">7</xref>). Indeed, in the present study, the Fsal rats were the sole fructose-fed animals exposed to a diet containing sizeable amounts of long-chain polyunsaturated &#x003C9;3 fatty acids (<xref rid="b1-mmr-06-06-1399" ref-type="bibr">1</xref>), this coinciding with a lower liver triglyceride content (P&lt;0.001) in the Fsal rats than in the Fsun or Fsaf rats. Furthermore, in the fructose-fed rats, a significant negative correlation prevailed between the individual values for liver glucokinase activity and liver triglyceride content (r&#x0003D;&#x02212;0.580; n&#x0003D;17; P&lt;0.02).</p>
<p>In terms of lipid metabolism, the salient findings comprised: the increased plasma concentration and liver content of cholesterol, triglycerides and phospholipids, but decreased plasma concentration of HDL-cholesterol in the Fsun rats, as compared with the Ssun rats; and the partial or complete correction of these perturbations in the Fsaf and Fsal rats, particularly in the latter. The internal consistency of these findings is further documented by the negative correlation found at the individual level between the total cholesterol concentration and that of HDL-cholesterol in plasma (r&#x0003D;&#x02212;0.537; n&#x0003D;23; P&lt;0.01). Likewise, the likely relationship between liver and plasma lipids is supported by the finding of close correlations between the individual values for the liver content of cholesterol, triglycerides and phospholipids and the plasma concentration of the same lipids (<xref rid="f2-mmr-06-06-1399" ref-type="fig">Fig. 2</xref>). The correlation coefficient in those three cases averaged 0.846&#x000B1;0.055 (n&#x0003D;3) with, in all cases, a probability well below 0.001 (n&#x0003D;23 in all three cases). Notably, the individual negative xy products represented no more than 1.6&#x000B1;0.8&#x00025; (n&#x0003D;3) of the corresponding positive xy products, no negative individual xy product being observed between the liver content and plasma concentration of triglycerides.</p>
<p>No clear difference in the protein content of the liver, heart, kidney or adipose tissue was observed among the four groups of rats. Nevertheless, the plasma albumin concentration was somewhat higher (P&lt;0.02 or less) in each group of fructose-fed rats than in the control starch-fed rats (<xref rid="tI-mmr-06-06-1399" ref-type="table">Table I</xref>). It was significantly lower, however, in the Fsal rats than in the Fsun or Fsaf rats (P&lt;0.001). Likewise, the plasma protein concentration was slightly higher (P&lt;0.05) in the fructose-fed rats than in the control starch-fed rats (data not shown). The correlation between the individual values for plasma albumin and protein concentrations was close to achieving statistical significance (r&#x0003D;&#x0002B;0.389; n&#x0003D;23; P&lt;0.07).</p>
<p>The urea and creatinine plasma concentrations were increased in the Fsun rats, with a trend towards normalization in the Fsaf and Fsal rats. Relative to the corresponding mean values found in Ssun rats (100.0&#x000B1;5.5&#x00025;; n&#x0003D;12), the measurements for the Fsun rats averaged 141.6&#x000B1;10.1&#x00025; (n&#x0003D;12; P&lt;0.002) and decreased to 132.0&#x000B1;8.9&#x00025; (n&#x0003D;12) in the Fsaf rats and 120.6&#x000B1;7.0&#x00025; (n&#x0003D;10) in the Fsal rats. The latter two mean values were significantly higher (P&lt;0.04 or less), however, than that determined in the Ssun rats. These findings may indicate incipient nephropathy in the fructose-fed rats.</p>
<p>Finally, the plasma concentration of calcium and iron also underwent dual changes. Relative to the mean value in Ssun rats (100.0&#x000B1;5.2&#x00025;; n&#x0003D;12), that in the Fsun rats was decreased (P&lt;0.001) to 75.5&#x000B1;3.5&#x00025; (n&#x0003D;12) and was distinctly different (P&lt;0.01 or less) from those in Fsaf (95.1&#x000B1;5.8&#x00025;, n&#x0003D;12) and Fsal rats (115.5&#x000B1;5.5&#x00025;; n&#x0003D;10). The latter value was not significantly higher (P&lt;0.06) than that recorded in the control Ssun rats. Changes in the plasma contribution of albumin are unlikely to act as determinants of changes in the plasma concentration of calcium, the correlation coefficient between these two variables (r&#x0003D;&#x02212;0.390; n&#x0003D;23; P&lt;0.07) being negative. As an alternative hypothesis, it may be speculated that the decrease in plasma calcium and iron concentration indicates an impaired intestinal absorption of these metals. To our knowledge, however, an enteropathy in animal models of diabetes mellitus has only been well-documented in type 1 diabetic animals such as BB rats (<xref rid="b8-mmr-06-06-1399" ref-type="bibr">8</xref>&#x02013;<xref rid="b10-mmr-06-06-1399" ref-type="bibr">10</xref>), in which case it was proposed that the enteropathy plays a role in the development of type 1 diabetes, rather than resulting from it (<xref rid="b11-mmr-06-06-1399" ref-type="bibr">11</xref>).</p>
<p>In summary, the present set of post-mortem data collected in rats exposed for 8 weeks to a fructose-rich diet and distinct oils confirms certain classical findings and reveals some unexpected features of the metabolic syndrome prevailing in fructose-fed rats, whilst duly documenting the favorable effect of diets enriched with selected long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids on minimizing the fructose-induced perturbations in several metabolic variables.</p></sec></body>
<back>
<ack>
<title>Acknowledgements</title>
<p>We are grateful to C. Demesmaeker for secretarial help.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-06-06-1399"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellouk</surname><given-names>Z</given-names></name><name><surname>Hachimi Idrissi</surname><given-names>T</given-names></name><name><surname>Louchami</surname><given-names>K</given-names></name><name><surname>Hupkens</surname><given-names>E</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Ait Yahia</surname><given-names>D</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name></person-group><article-title>The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids. I Intraperitoneal glucose tolerance test</article-title><source>Int J Mol Med</source><volume>28</volume><fpage>1087</fpage><lpage>1092</lpage><year>2011</year></element-citation></ref>
<ref id="b2-mmr-06-06-1399"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellouk</surname><given-names>Z</given-names></name><name><surname>Hachimi Idrissi</surname><given-names>T</given-names></name><name><surname>Louchami</surname><given-names>K</given-names></name><name><surname>Hupkens</surname><given-names>E</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Ait Yahia</surname><given-names>D</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name></person-group><article-title>The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids. II Time course of changes in food intake, body weight, plasma glucose and insulin concentrations and insulin resistance</article-title><source>Int J Mol Med</source><volume>29</volume><fpage>113</fpage><lpage>118</lpage><year>2012</year></element-citation></ref>
<ref id="b3-mmr-06-06-1399"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellouk</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bulur</surname><given-names>N</given-names></name><name><surname>Louchami</surname><given-names>K</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Ait Yahia</surname><given-names>D</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name></person-group><article-title>The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids. III Secretory behaviour of isolated pancreatic islets</article-title><source>Int J Mol Med</source><volume>29</volume><fpage>285</fpage><lpage>290</lpage><year>2012</year></element-citation></ref>
<ref id="b4-mmr-06-06-1399"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mellouk</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bulur</surname><given-names>N</given-names></name><name><surname>Louchami</surname><given-names>K</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Ait Yahia</surname><given-names>D</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name></person-group><article-title>The metabolic syndrome of fructose-fed rats: effects of long-chain polyunsaturated &#x003C9;3 and &#x003C9;6 fatty acids. IV D-glucose metabolism in isolated pancreatic islets</article-title><source>Int J Mol Med</source><volume>29</volume><fpage>291</fpage><lpage>293</lpage><year>2012</year></element-citation></ref>
<ref id="b5-mmr-06-06-1399"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boukortt</surname><given-names>FO</given-names></name><name><surname>Madani</surname><given-names>Z</given-names></name><name><surname>Mellouk</surname><given-names>Z</given-names></name><name><surname>Louchami</surname><given-names>K</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Ait Yahia</surname><given-names>D</given-names></name></person-group><article-title>Nutritional factors and fructose-induced metabolic syndrome</article-title><source>Metab Funct Res Diab</source><volume>4</volume><fpage>18</fpage><lpage>34</lpage><year>2011</year></element-citation></ref>
<ref id="b6-mmr-06-06-1399"><label>6</label><element-citation publication-type="book"><person-group person-group-type="editor"><name><surname>Lowry</surname><given-names>OH</given-names></name><name><surname>Passonneau</surname><given-names>JV</given-names></name></person-group><source>A Flexible System of Enzymatic Analysis</source><publisher-name>Academic Press</publisher-name><publisher-loc>New York</publisher-loc><fpage>174</fpage><year>1972</year></element-citation></ref>
<ref id="b7-mmr-06-06-1399"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Bulur</surname><given-names>N</given-names></name><name><surname>Peltier</surname><given-names>S</given-names></name><name><surname>Carpentier</surname><given-names>YA</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name></person-group><article-title>Long-chain fatty acyl-coenzyme A-induced inhibition of glucokinase in islets from rats depleted in long-chain polyunsaturated &#x003C9;3 fatty acids</article-title><source>Cell Biochem Funct</source><volume>26</volume><fpage>233</fpage><lpage>237</lpage><year>2008</year></element-citation></ref>
<ref id="b8-mmr-06-06-1399"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtois</surname><given-names>P</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name></person-group><article-title>Disaccharidase activity in the intestinal tract of Wistar-Furth, BBc and BBdp rats</article-title><source>Br J Nutr</source><volume>91</volume><fpage>201</fpage><lpage>209</lpage><year>2004</year></element-citation></ref>
<ref id="b9-mmr-06-06-1399"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courtois</surname><given-names>P</given-names></name><name><surname>Sener</surname><given-names>A</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name></person-group><article-title>Peroxidase activity in the intestinal tract of Wistar-Furth, BBc and BBdp rats</article-title><source>Diabetes Metab Res Rev</source><volume>20</volume><fpage>305</fpage><lpage>314</lpage><year>2004</year></element-citation></ref>
<ref id="b10-mmr-06-06-1399"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>S</given-names></name><name><surname>Courtois</surname><given-names>P</given-names></name><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Rozing</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name><name><surname>Mowat</surname><given-names>AM</given-names></name></person-group><article-title>Enteropathy precedes type 1 diabetes in the BB rat</article-title><source>Gut</source><volume>53</volume><fpage>1437</fpage><lpage>1444</lpage><year>2004</year></element-citation></ref>
<ref id="b11-mmr-06-06-1399"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malaisse</surname><given-names>WJ</given-names></name><name><surname>Courtois</surname><given-names>P</given-names></name><name><surname>Scott</surname><given-names>FW</given-names></name></person-group><article-title>Insulin-dependent diabetes and gut dysfunction: the BB rat model</article-title><source>Horm Metab Res</source><volume>36</volume><fpage>585</fpage><lpage>594</lpage><year>2004</year></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-mmr-06-06-1399" position="float">
<label>Figure 1</label>
<caption>
<p>Metabolic parameters in Fsun (&#x025CF;), Fsaf (&#x025B3;) and Fsal (x) rats. Mean values (&#x000B1; SEM) for (A) the percentage of glycated hemoglobin, (B) liver cholesterol, triglycerides and phospholipid content, (C) plasma concentration of albumin, urea, creatinine, phospholipids, triglycerides and total cholesterol, (D) plasma concentration of calcium, iron and HDL-cholesterol, (E) blood hemoglobin concentration and liver protein content and (F) liver glucokinase activity in Fsun, Fsaf and Fsal rats are expressed relative to the mean corresponding values found in Ssun rats (&#x025CB;). They refer to (A and F) 5&#x02013;6 individual data, (E) 10&#x02013;12 individual data, (B and D) 15&#x02013;18 individual data and (C) 30&#x02013;36 individual data.</p></caption>
<graphic xlink:href="MMR-06-06-1399-g00.gif"/></fig>
<fig id="f2-mmr-06-06-1399" position="float">
<label>Figure 2</label>
<caption>
<p>Comparison between the plasma concentration and liver content of cholesterol, triglycerides and phospholipids in Ssun (&#x025CB;), Fsun (&#x025CF;), Fsal (x) and Fsaf (&#x025B3;) rats. The oblique lines correspond to the regression lines with slopes equal to the square root of the quotient (&#x02211;y<sup>2</sup>/&#x02211;x<sup>2</sup>) between the sum of the squared individual differences from mean values in plasma concentration (&#x02211;y<sup>2</sup>) and the sum of the squared individual differences from mean values in liver content (&#x02211;x<sup>2</sup>).</p></caption>
<graphic xlink:href="MMR-06-06-1399-g01.gif"/></fig>
<table-wrap id="tI-mmr-06-06-1399" position="float">
<label>Table I</label>
<caption>
<p>Plasma data.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">Ssun (n&#x0003D;6)</th>
<th align="center" valign="bottom">Fsun (n&#x0003D;6)</th>
<th align="center" valign="bottom">Fsal (n&#x0003D;5)</th>
<th align="center" valign="bottom">Fsaf (n&#x0003D;6)</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Albumin (g/l)</td>
<td align="right" valign="top">39.2&#x000B1;0.23</td>
<td align="right" valign="top">42.00&#x000B1;0.24</td>
<td align="right" valign="top">40.26&#x000B1;0.24</td>
<td align="right" valign="top">41.67&#x000B1;0.15</td></tr>
<tr>
<td align="left" valign="top">Urea (mM)</td>
<td align="right" valign="top">2.29&#x000B1;0.22</td>
<td align="right" valign="top">3.04&#x000B1;0.09</td>
<td align="right" valign="top">2.74&#x000B1;0.09</td>
<td align="right" valign="top">2.84&#x000B1;0.09</td></tr>
<tr>
<td align="left" valign="top">Creatinine (mg/dl)</td>
<td align="right" valign="top">1.25&#x000B1;0.13</td>
<td align="right" valign="top">1.88&#x000B1;0.25</td>
<td align="right" valign="top">1.52&#x000B1;0.18</td>
<td align="right" valign="top">1.75&#x000B1;0.22</td></tr>
<tr>
<td align="left" valign="top">Calcium (mM)</td>
<td align="right" valign="top">2.21&#x000B1;0.03</td>
<td align="right" valign="top">1.75&#x000B1;0.01</td>
<td align="right" valign="top">2.36&#x000B1;0.02</td>
<td align="right" valign="top">2.38&#x000B1;0.02</td></tr>
<tr>
<td align="left" valign="top">Iron (&#x003BC;M)</td>
<td align="right" valign="top">12.33&#x000B1;1.33</td>
<td align="right" valign="top">8.86&#x000B1;0.85</td>
<td align="right" valign="top">15.28&#x000B1;1.22</td>
<td align="right" valign="top">10.15&#x000B1;1.13</td></tr>
<tr>
<td align="left" valign="top">Phospholipids (mM)</td>
<td align="right" valign="top">1.20&#x000B1;0.04</td>
<td align="right" valign="top">2.50&#x000B1;0.06</td>
<td align="right" valign="top">1.56&#x000B1;0.05</td>
<td align="right" valign="top">1.69&#x000B1;0.05</td></tr>
<tr>
<td align="left" valign="top">Triglycerides (mM)</td>
<td align="right" valign="top">3.19&#x000B1;0.05</td>
<td align="right" valign="top">5.12&#x000B1;0.18</td>
<td align="right" valign="top">3.55&#x000B1;0.15</td>
<td align="right" valign="top">4.86&#x000B1;0.17</td></tr>
<tr>
<td align="left" valign="top">Total cholesterol (mM)</td>
<td align="right" valign="top">3.22&#x000B1;0.04</td>
<td align="right" valign="top">4.15&#x000B1;0.03</td>
<td align="right" valign="top">3.35&#x000B1;0.24</td>
<td align="right" valign="top">3.87&#x000B1;0.14</td></tr>
<tr>
<td align="left" valign="top">HDL-cholesterol (mM)</td>
<td align="right" valign="top">2.82&#x000B1;0.11</td>
<td align="right" valign="top">2.15&#x000B1;0.19</td>
<td align="right" valign="top">3.05&#x000B1;0.36</td>
<td align="right" valign="top">2.33&#x000B1;0.08</td></tr></tbody></table></table-wrap>
<table-wrap id="tII-mmr-06-06-1399" position="float">
<label>Table II</label>
<caption>
<p>Blood data.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">Ssun (n&#x0003D;6)</th>
<th align="center" valign="bottom">Fsun (n&#x0003D;6)</th>
<th align="center" valign="bottom">Fsal (n&#x0003D;5)</th>
<th align="center" valign="bottom">Fsaf (n&#x0003D;6)</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Hemoglobin (mg/ml)</td>
<td align="center" valign="top">474&#x000B1;74</td>
<td align="center" valign="top">532&#x000B1;82</td>
<td align="center" valign="top">483&#x000B1;68</td>
<td align="center" valign="top">522&#x000B1;77</td></tr>
<tr>
<td align="left" valign="top">Glycated hemoglobin (&#x00025;)</td>
<td align="center" valign="top">5.81&#x000B1;0.02</td>
<td align="center" valign="top">13.67&#x000B1;0.13</td>
<td align="center" valign="top">8.76&#x000B1;0.02</td>
<td align="center" valign="top">12.11&#x000B1;0.02</td></tr></tbody></table></table-wrap>
<table-wrap id="tIII-mmr-06-06-1399" position="float">
<label>Table III</label>
<caption>
<p>Liver data.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom"/>
<th align="center" valign="bottom">Ssun</th>
<th align="center" valign="bottom">Fsun</th>
<th align="center" valign="bottom">Fsal</th>
<th align="center" valign="bottom">Fsaf</th></tr></thead>
<tbody>
<tr>
<td align="left" valign="top">Protein (&#x003BC;g/mg wet wt.)</td>
<td align="center" valign="top">209&#x000B1;8<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">204&#x000B1;17<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">192&#x000B1;18<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">210&#x000B1;14<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">Glucokinase activity (nmol/mg wet wt. per 30 min)</td>
<td align="center" valign="top">6.05&#x000B1;0.27<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">6.37&#x000B1;0.21<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">8.77&#x000B1;0.86<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">6.78&#x000B1;0.24<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">Cholesterol (&#x003BC;mol/g wet wt.)</td>
<td align="center" valign="top">32.50&#x000B1;0.66<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">44.41&#x000B1;0.36<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">35.89&#x000B1;0.37<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">38.72&#x000B1;0.22<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">Triglycerides (&#x003BC;mol/g wet wt.)</td>
<td align="center" valign="top">23.39&#x000B1;0.34<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">36.85&#x000B1;0.33<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">28.56&#x000B1;0.48<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">34.44&#x000B1;0.51<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td></tr>
<tr>
<td align="left" valign="top">Phospholipids (&#x003BC;mol/g wet wt.)</td>
<td align="center" valign="top">18.62&#x000B1;0.48<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">32.48&#x000B1;0.25<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td>
<td align="center" valign="top">22.72&#x000B1;0.33<xref rid="tfn2-mmr-06-06-1399" ref-type="table-fn">b</xref></td>
<td align="center" valign="top">28.35&#x000B1;0.31<xref rid="tfn1-mmr-06-06-1399" ref-type="table-fn">a</xref></td></tr></tbody></table>
<table-wrap-foot><fn id="tfn1-mmr-06-06-1399">
<label>a</label>
<p>n&#x0003D;6;</p></fn><fn id="tfn2-mmr-06-06-1399">
<label>b</label>
<p>n&#x0003D;5.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
